http://www.fpnotebook.com/
QuazepamAka: Doral
- See Also
- Class
- Long acting Benzodiazepine
- Indications
- Dose
- Insomnia
- 7.5-30 mg PO qhs
- Anxiety
- Maximum Daily Dose: 15 mg
- Insomnia
- Pharmacokinetics
- Half-Life: 39 hours
- Background
- Weekly Cost: $5.08
quazepam (C0072828) | |
|---|---|
| Definition (NCI) | A synthetic benzodiazepine derivative with anxiolytic, sedative and hypnotic properties. Quazepam and its major metabolite 2-oxoquazepam potentiate gamma-aminobutyric acid (GABA) activity by binding to the benzodiazepine-1 recognition site (BZ-1) within the GABA-A receptor, located in the limbic, neocortical and mesencephalic reticular system. This increases the frequency of GABA-activated chloride channel opening events, allowing the flow of chloride ions into the neuron leading to membrane hyperpolarization and decreased neuronal excitability. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C025130 |
| English | quazepam, QUAZEPAM PREPARATION, Quazepam product |
| Spanish | cuacepam, cuazepam |
| Parent Concepts | Benzodiazepines (C0005064), [CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS (C0973503), Unclassified Ingredients (C1372954), Benzodiazepine sedative (C0360114) |
| Sources | LNC, MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Doral (C0720023) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C025130 |
| English | Doral, Wallace brand of quazepam |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |